IL122420A - Polymorphic form of doxazosin mesylate (form I) and pharmaceutical compositions comprising it - Google Patents
Polymorphic form of doxazosin mesylate (form I) and pharmaceutical compositions comprising itInfo
- Publication number
- IL122420A IL122420A IL12242097A IL12242097A IL122420A IL 122420 A IL122420 A IL 122420A IL 12242097 A IL12242097 A IL 12242097A IL 12242097 A IL12242097 A IL 12242097A IL 122420 A IL122420 A IL 122420A
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical compositions
- doxazosin mesylate
- polymorphic
- polymorphic form
- doxazosin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96120601A EP0849264A1 (de) | 1996-12-20 | 1996-12-20 | Neue polymorphe Form von doxazosinmesylat (Form I) |
Publications (2)
Publication Number | Publication Date |
---|---|
IL122420A0 IL122420A0 (en) | 1998-06-15 |
IL122420A true IL122420A (en) | 2000-06-01 |
Family
ID=8223529
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL12242097A IL122420A (en) | 1996-12-20 | 1997-12-02 | Polymorphic form of doxazosin mesylate (form I) and pharmaceutical compositions comprising it |
Country Status (10)
Country | Link |
---|---|
US (1) | US6130218A (xx) |
EP (1) | EP0849264A1 (xx) |
JP (1) | JPH10182639A (xx) |
KR (1) | KR19980064286A (xx) |
CA (1) | CA2224916A1 (xx) |
HU (1) | HUP9702480A3 (xx) |
IL (1) | IL122420A (xx) |
NZ (1) | NZ329404A (xx) |
TW (1) | TW420678B (xx) |
ZA (1) | ZA9710632B (xx) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19800214A1 (de) | 1998-01-06 | 1999-07-15 | Knoll Ag | Verfahren zur Herstellung von Doxazosin-Mcsylat in einer als Form A bezeichneten Kristallmodifikation und ein Zwischenprodukt dafür |
US6706721B1 (en) * | 1998-04-29 | 2004-03-16 | Osi Pharmaceuticals, Inc. | N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate |
ES2164520B1 (es) | 1999-03-16 | 2003-04-01 | Medichem Sa | "procedimiento de obtencion del polimorfo a del mesilato de doxazosina" |
DE19912573A1 (de) * | 1999-03-19 | 2000-09-21 | Knoll Ag | Arzneimittel, enthaltend Doxazosin-Mesylat der Kristallmodifikaton D |
UA74803C2 (uk) * | 1999-11-11 | 2006-02-15 | Осі Фармасьютікалз, Інк. | Стійкий поліморф гідрохлориду n-(3-етинілфеніл)-6,7-біс(2-метоксіетокси)-4-хіназолінаміну, спосіб його одержання (варіанти) та фармацевтичне застосування |
US7087613B2 (en) * | 1999-11-11 | 2006-08-08 | Osi Pharmaceuticals, Inc. | Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride |
JP2011507938A (ja) | 2007-12-24 | 2011-03-10 | シプラ・リミテッド | メシル酸ドキサゾシンの結晶多形(形態iv)及びその製造方法 |
CN109988158A (zh) * | 2018-01-03 | 2019-07-09 | 合肥立方制药股份有限公司 | X晶型、含有x晶型的多沙唑嗪甲磺酸盐及其制备方法和用途 |
KR20190119416A (ko) | 2018-04-12 | 2019-10-22 | 조선대학교산학협력단 | 다이빙 후드 |
CN111303130B (zh) * | 2018-12-11 | 2021-09-14 | 合肥立方制药股份有限公司 | 一种多沙唑嗪甲磺酸盐晶型、其制备方法及用途 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2699054A (en) * | 1953-10-09 | 1955-01-11 | Lloyd H Conover | Tetracycline |
US4092315A (en) * | 1976-03-01 | 1978-05-30 | Pfizer Inc. | Novel crystalline forms of prazosin hydrochloride |
GB1591490A (en) * | 1977-08-04 | 1981-06-24 | Abbott Lab | 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate |
DK154082C (da) * | 1977-11-05 | 1989-02-27 | Pfizer | Analogifremgangsmaade til fremstilling af 4-amino-6,7-dimethoxy-2-(piperazin-1-yl eller homopiperazin-1-yl)-quinazolinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf |
US4188390A (en) | 1977-11-05 | 1980-02-12 | Pfizer Inc. | Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines |
ATE72244T1 (de) * | 1986-03-21 | 1992-02-15 | Heumann Pharma Gmbh & Co | Kristalline, wasserfreie sigma -form von 2-(4-(2furoyl-(2-piperazin)-1-yl>-4-amino-6,7- dimethoxychinazolinhydrochlorid und verfahren zu ihrer herstellung. |
DK0459666T3 (da) * | 1990-05-31 | 1994-12-05 | Pfizer | Lægemidler mod impotens |
AU5457694A (en) * | 1992-11-04 | 1994-05-24 | Sepracor, Inc. | Methods and compositions of (-) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis |
US5294615A (en) * | 1993-04-29 | 1994-03-15 | Abbott Laboratories | Terazosin polymorph and pharmaceutical composition |
US5412095A (en) * | 1993-04-29 | 1995-05-02 | Abbott Laboratories | Terazosin monohydrochloride and processes and intermediate for its production |
US5504207A (en) * | 1994-10-18 | 1996-04-02 | Abbott Laboratories | Process and intermediate for the preparation of terazosin hydrochloride dihydrate |
-
1996
- 1996-12-20 EP EP96120601A patent/EP0849264A1/de not_active Withdrawn
-
1997
- 1997-01-01 ZA ZA9710632A patent/ZA9710632B/xx unknown
- 1997-12-02 IL IL12242097A patent/IL122420A/xx not_active IP Right Cessation
- 1997-12-03 TW TW086118163A patent/TW420678B/zh active
- 1997-12-16 NZ NZ329404A patent/NZ329404A/xx not_active IP Right Cessation
- 1997-12-16 CA CA002224916A patent/CA2224916A1/en not_active Abandoned
- 1997-12-16 HU HU9702480A patent/HUP9702480A3/hu unknown
- 1997-12-17 US US08/992,252 patent/US6130218A/en not_active Expired - Lifetime
- 1997-12-17 KR KR1019970070177A patent/KR19980064286A/ko not_active Application Discontinuation
- 1997-12-17 JP JP9364069A patent/JPH10182639A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
TW420678B (en) | 2001-02-01 |
CA2224916A1 (en) | 1998-06-20 |
JPH10182639A (ja) | 1998-07-07 |
AU4690497A (en) | 1998-06-25 |
KR19980064286A (ko) | 1998-10-07 |
ZA9710632B (en) | 1998-11-11 |
HU9702480D0 (en) | 1998-03-02 |
IL122420A0 (en) | 1998-06-15 |
US6130218A (en) | 2000-10-10 |
HUP9702480A2 (hu) | 1999-04-28 |
HUP9702480A3 (en) | 1999-06-28 |
EP0849264A1 (de) | 1998-06-24 |
AU720753B2 (en) | 2000-06-08 |
NZ329404A (en) | 1999-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0004802A3 (en) | Nicotine compositions and methods of formulation thereof | |
IL120141A0 (en) | Substituted quinazoline derivatives and pharmaceutical compositions containing them | |
HUP0101580A3 (en) | Pharmaceutical compositions capable of being gelled | |
HUP9702035A3 (en) | Inhibitors of leukocita-adhesion- and vla-4-antagonists and pharmaceutical compositions containing them | |
HUP9702036A3 (en) | Inhibitors of leucocita-adhesion and wla-4-antagonists and pharmaceutical compositions containing them | |
HUP9702034A3 (en) | Inhibitors of leukocita-adhesion and vla-4-antagonists and pharmaceutical compositions containing them | |
HUP0103406A3 (en) | 1h-imidazopyridine derivatives and pharmaceutical compositions thereof | |
IL138453A0 (en) | Peptide compositions and formulations and use of same | |
HUP0103874A3 (en) | Use of antibiotics and pharmaceutical compositions comprising thereof | |
HUP0004318A3 (en) | Pharmaceutical composition comprising atorvastatin and an antihypertensive agent | |
HUP0102990A3 (en) | Tetrahydroimidazo-naphtyridine derivatives and pharmaceutical compositions thereof | |
HUP9900424A2 (hu) | Tiazolil-benzfurán-származékok és a vegyületeket tartalmazó gyógyászati készítmények | |
ZA971964B (en) | Azolobenzazepine derivatives and compositions and method of use thereof. | |
EP1076547A4 (en) | ARABINOGALACTANE DERIVATIVES AND COMPOSITIONS CONTAINING THEM | |
PT977812E (pt) | Composições asfálticas e respectivos métodos de preparação | |
GB9710800D0 (en) | Pharmaceutical composition and method of preparing it | |
HUP0103203A3 (en) | Azaadamantane derivatives and pharmaceutical compositions thereof | |
PL334092A1 (en) | Prodrug forms of novel camphotecin analogues and their application as drugs | |
HUP0101749A3 (en) | Formulations for protection of peg-interferon alpha conjugates and method for preparation such formulations | |
IL122420A (en) | Polymorphic form of doxazosin mesylate (form I) and pharmaceutical compositions comprising it | |
IL120669A0 (en) | Benzylamine derivatives and pharmaceutical compositions containing them | |
HUP0101701A3 (en) | Substituted betha-alanines and pharmaceutical compositions comprising them | |
HUP0002331A3 (en) | 20-aralkyl-5alpha-pregnane derivatives and pharmaceutical compositions thereof | |
PT1140110E (pt) | Clatratos de desidroepiandrosterona e correspondentes composicoes farmaceuticas | |
HUP9904301A3 (en) | Benzimidazole derivatives and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
EXP | Patent expired |